Imaging the Effects of Castration on Bone Turnover and Hormone-Independent Prostate Cancer Colonization of Bone

被引:5
|
作者
Cross, N. A. [1 ]
Fowles, A. [2 ]
Reeves, K. [2 ]
Jokonya, N. [2 ]
Linton, K. [2 ]
Holen, I. [2 ]
Hamdy, F. C. [2 ]
Eaton, C. L. [2 ]
机构
[1] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Urol Sect, Sheffield, S Yorkshire, England
来源
PROSTATE | 2008年 / 68卷 / 15期
基金
英国医学研究理事会;
关键词
androgens; osteolytic; osteoblast; osteoclast;
D O I
10.1002/pros.20833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION. Tumor populations may selectively colonize bone that is being actively remodeled. In prostate cancer patients, androgen deprivation directly inhibits tumor growth initially, whilst induced bone loss may facilitate tumor colonization of bone by androgen-insensitive cells. We have tested this hypothesis using a xenograft model of early growth of prostate cancer in bone. METHODS. PC3 cells transfected with Green fluorescent protein (GFP) were injected into castrated and non-castrated athymic mice via intrabial and intracardiac routes. In vivo tumor growth was monitored daily and animals sacrificed 6-9 days following initial GFP-based detection of tumors. Tumor bearing and contra-lateral non-tumor bearing tibias were analyzed extensively by micro-CT and histology/immunohistochemistry for the presence of tumor cells and the effects of tumor and/or castration on bone cells and bone structure evaluated. RESULTS. GFP-positive tumors in bone were visible from 12 days post-injection following intratibial injection, allowing tumors <1 mm diameter to be monitored in live animals. Castration did not affect tumor frequency, tumor volume, or time to initial appearance of tumors injected via intratibial or intracardiac routes. Castration decreased trabecular bone volume in all mice. Significant tumor-induced suppression of numbers of osteoblasts, coupled with increased numbers of activated osteoclasts, was evident in both intact animals and castrated animals. CONCLUSIONS. In vivo GFP imaging allows the detection of early tumor growth at intra-osseous sites. Castration induces bone loss, but PC3-GFP cells are also capable of inducing bone remodeling in intact animals at early time points, independently of pre-existing castration-induced alterations to bone. Prostate 68: 1707-1714, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1707 / 1714
页数:8
相关论文
共 50 条
  • [1] HORMONE-INDEPENDENT CANCER OF THE PROSTATE
    GRAVES, RC
    DESAUTELS, RE
    WARREN, S
    JOURNAL OF UROLOGY, 1958, 79 (02): : 324 - 332
  • [2] Molecular aspects of hormone-independent prostate cancer
    Schalken, Jack A.
    BJU INTERNATIONAL, 2007, 100 : 52 - 55
  • [3] Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
    Monica M Richert
    Pushkar A Phadke
    Gail Matters
    Douglas J DiGirolamo
    Sharlene Washington
    Laurence M Demers
    Judith S Bond
    Andrea Manni
    Danny R Welch
    Breast Cancer Research, 7
  • [4] Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment
    Richert, MM
    Phadke, PA
    Matters, G
    DiGirolamo, DJ
    Washington, S
    Demers, LM
    Bond, JS
    Manni, A
    Welch, DR
    BREAST CANCER RESEARCH, 2005, 7 (05) : R819 - R827
  • [5] The effects of castration on prostate cancer tumor growth in bone
    Kahkonen, Tiina E.
    Suominen, Mari I.
    Maki-Jouppila, Jenni
    Halleen, Jussi M.
    Bernoulli, Jenni
    Lejeune, Pascale
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 339 - 339
  • [6] New strategies for the treatment of hormone-independent prostate cancer
    DWW Newling
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 290 - 295
  • [7] Secondary hormonal ablation in hormone-independent prostate cancer
    Schilling, D.
    Gakis, G.
    Boekeler, U.
    Stenzl, A.
    Kuczyk, M. A.
    Merseburger, A. S.
    UROLOGE, 2009, 48 (02): : 183 - 188
  • [8] New strategies for the treatment of hormone-independent prostate cancer
    Newling, DWW
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 290 - 295
  • [9] Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
    Wegiel, B.
    Evans, S.
    Hellsten, R.
    Otterbein, L. E.
    Bjartell, A.
    Persson, J. L.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (04) : 392 - 401
  • [10] Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer
    Kim, Jae Sik
    Lee, Sang Don
    Lee, Sang Jin
    Chung, Moon Kee
    ONCOTARGETS AND THERAPY, 2013, 6 : 1635 - 1642